The Corner

RE: “100 MILLION AMERICANS”

Rep. Mark Souder recently asked James Battey, the head of the NIH task force on stem cells, about this number. (Battey had testified before Souder’s committee, and Souder sent some written questions to follow up.) Q. “A common figure tossed around regarding the ‘promise’ of embryonic stem cell research is that it can provide cures for 100 million people. Is there any scientific evidence to actually support that claim?” A. “It is unclear where this statistic came from.  Human embryonic stem cell (hESC) research is a relatively new field of science, having been first reported by James Thomson at the University of Wisconsin in 1998.  More basic research needs to be conducted in the laboratory before the full potential for treating diseases is clear.”

Ramesh Ponnuru is a senior editor for National Review, a columnist for Bloomberg Opinion, a visiting fellow at the American Enterprise Institute, and a senior fellow at the National Review Institute.

Most Popular

Politics & Policy

Ten Questions for the ‘Squad’

Democratic infighting reached a fever pitch last week with bickering and personal attacks between members of the “Squad” and other House Democrats. During that period, Squad members Alexandria Ocasio-Cortez, Ilhan Omar, Rashida Tlaib, and Ayanna Pressley mostly avoided doing interviews. However, that all ... Read More
World

Who Is Boris Johnson?

By next week at this time, Boris Johnson will be prime minister of the United Kingdom. Not since Margaret Thatcher has such an outsized personality resided in Number 10 Downing Street. Not since Winston Churchill has such a wit presided over Her Majesty’s Government. Wit is actually the chief reason for ... Read More
Health Care

For Planned Parenthood, No Doctors Need Apply

Poor Leana Wen. She took Planned Parenthood’s propaganda a little too seriously. And now she’s out of a job. For the longest time, Planned Parenthood has insisted that it’s a health-care organization, and it only cares about abortion — supposedly a tiny share of its business — insofar as it’s a ... Read More